Your browser doesn't support javascript.
Acute Cardiac Events During COVID-19-Associated Hospitalizations.
Woodruff, Rebecca C; Garg, Shikha; George, Mary G; Patel, Kadam; Jackson, Sandra L; Loustalot, Fleetwood; Wortham, Jonathan M; Taylor, Christopher A; Whitaker, Michael; Reingold, Arthur; Alden, Nisha B; Meek, James; Anderson, Evan J; Weigel, Andy; Henderson, Justin; Bye, Erica; Davis, Sarah Shrum; Barney, Grant; Bennett, Nancy M; Shiltz, Eli; Sutton, Melissa; Talbot, H Keipp; Price, Andrea; Sperling, Laurence S; Havers, Fiona P.
  • Woodruff RC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Electronic address
  • Garg S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA.
  • George MG; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Patel K; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; General Dynamics Information Technology, Atlanta, Georgia, USA.
  • Jackson SL; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Loustalot F; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA.
  • Wortham JM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA.
  • Taylor CA; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Whitaker M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Reingold A; University of California, Berkeley, California, USA; California Emerging Infections Program, Oakland, California, USA.
  • Alden NB; Colorado Department of Public Health and Environment, Denver, Colorado, USA.
  • Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.
  • Anderson EJ; Departments of Medicine and Pediatrics, Emory School of Medicine, Atlanta, Georgia, USA; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, Georgia, USA; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Weigel A; Iowa Department of Public Health, Des Moines, Iowa, USA.
  • Henderson J; Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • Bye E; Minnesota Department of Health, St Paul, Minnesota, USA.
  • Davis SS; New Mexico Emerging Infections Program, Albuquerque, New Mexico, USA.
  • Barney G; New York State Department of Health, Albany, New York, USA.
  • Bennett NM; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Shiltz E; Ohio Department of Health, Columbus, Ohio, USA.
  • Sutton M; Public Health Division, Oregon Health Authority, Portland, Oregon, USA.
  • Talbot HK; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Price A; Salt Lake County Health Department, Salt Lake City, Utah, USA.
  • Sperling LS; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Havers FP; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA.
J Am Coll Cardiol ; 81(6): 557-569, 2023 02 14.
Article in English | MEDLINE | ID: covidwho-2286964
ABSTRACT

BACKGROUND:

COVID-19 is associated with cardiac complications.

OBJECTIVES:

The purpose of this study was to estimate the prevalence, risk factors, and outcomes associated with acute cardiac events during COVID-19-associated hospitalizations among adults.

METHODS:

During January 2021 to November 2021, medical chart abstraction was conducted on a probability sample of adults hospitalized with laboratory-confirmed SARS-CoV-2 infection identified from 99 U.S. counties in 14 U.S. states in the COVID-19-Associated Hospitalization Surveillance Network. We calculated the prevalence of acute cardiac events (identified by International Classification of Diseases-10th Revision-Clinical Modification codes) by history of underlying cardiac disease and examined associated risk factors and disease outcomes.

RESULTS:

Among 8,460 adults, 11.4% (95% CI 10.1%-12.9%) experienced an acute cardiac event during a COVID-19-associated hospitalization. Prevalence was higher among adults who had underlying cardiac disease (23.4%; 95% CI 20.7%-26.3%) compared with those who did not (6.2%; 95% CI 5.1%-7.6%). Acute ischemic heart disease (5.5%; 95% CI 4.5%-6.5%) and acute heart failure (5.4%; 95% CI 4.4%-6.6%) were the most prevalent events; 0.3% (95% CI 0.1%-0.5%) experienced acute myocarditis or pericarditis. Risk factors varied by underlying cardiac disease status. Patients with ≥1 acute cardiac event had greater risk of intensive care unit admission (adjusted risk ratio 1.9; 95% CI 1.8-2.1) and in-hospital death (adjusted risk ratio 1.7; 95% CI 1.3-2.1) compared with those who did not.

CONCLUSIONS:

Acute cardiac events were common during COVID-19-associated hospitalizations, particularly among patients with underlying cardiac disease, and are associated with severe disease outcomes. Persons at greater risk for experiencing acute cardiac events during COVID-19-associated hospitalizations might benefit from more intensive clinical evaluation and monitoring during hospitalization.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Diseases Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Humans Language: English Journal: J Am Coll Cardiol Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Diseases Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Humans Language: English Journal: J Am Coll Cardiol Year: 2023 Document Type: Article